HIGHLIGHTS
- who: MustafaRaoof from the Hope National Medical Center, Duarte, CA, USA have published the Article: Pleura and Peritoneum, in the Journal: (JOURNAL)
- what: The authors aim to conduct a dose-escalation trial of mitomycin C (MMC)-PIPAC combined with systemic chemotherapy (FOLFIRI) in patients with PM from appendiceal cancer or CRC.
- future: As tolerance and cumulative toxicity likely differs for PIPAC with multimodal therapy further studies are required to determine the optimal dose of PIPAC drugs in combination therapy.
SUMMARY
Clinical experience with PIPAC in CRC and AC Several . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.